153 related articles for article (PubMed ID: 21428887)
1. Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.
Labropoulou VT; Theocharis AD; Symeonidis A; Skandalis SS; Karamanos NK; Kalofonos HP
Curr Med Chem; 2011; 18(11):1584-98. PubMed ID: 21428887
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease.
Bataille R; Chappard D; Marcelli C; Dessauw P; Sany J; Baldet P; Alexandre C
J Clin Oncol; 1989 Dec; 7(12):1909-14. PubMed ID: 2585025
[TBL] [Abstract][Full Text] [Related]
3. [Bone disease in multiple myeloma and its mechanism].
Abe M
Clin Calcium; 2006 Apr; 16(4):565- 71. PubMed ID: 16582506
[TBL] [Abstract][Full Text] [Related]
4. Myeloma bone disease.
Sezer O
Hematology; 2005; 10 Suppl 1():19-24. PubMed ID: 16188625
[TBL] [Abstract][Full Text] [Related]
5. Emerging treatment approaches for myeloma-related bone disease.
Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and management of myeloma bone disease.
Christoulas D; Terpos E; Dimopoulos MA
Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms, current management and next generation therapy in myeloma bone disease.
Heusschen R; Muller J; Duray E; Withofs N; Bolomsky A; Baron F; Beguin Y; Menu E; Ludwig H; Caers J
Leuk Lymphoma; 2018 Jan; 59(1):14-28. PubMed ID: 28573897
[TBL] [Abstract][Full Text] [Related]
8. Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.
Yee AJ; Raje NS
Future Oncol; 2018 Feb; 14(3):195-203. PubMed ID: 29052442
[TBL] [Abstract][Full Text] [Related]
9. Myeloma bone disease: Progress in pathogenesis.
Xi H; An R; Li L; Wang G; Tao Y; Gao L
Prog Biophys Mol Biol; 2016 Nov; 122(2):149-155. PubMed ID: 27496181
[TBL] [Abstract][Full Text] [Related]
10. New agents in the Treatment of Myeloma Bone Disease.
Ring ES; Lawson MA; Snowden JA; Jolley I; Chantry AD
Calcif Tissue Int; 2018 Feb; 102(2):196-209. PubMed ID: 29098361
[TBL] [Abstract][Full Text] [Related]
11. Myeloma bone disease: pathogenesis, current treatments and future targets.
Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
[TBL] [Abstract][Full Text] [Related]
12. Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
Kleber M; Udi J; Metzke B; Terpos E; Roodmann GD; Morgan G; Dispenzieri A; Einsele H; Wäsch R; Engelhardt M
Leuk Lymphoma; 2012 Jun; 53(6):1057-61. PubMed ID: 22149167
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
[TBL] [Abstract][Full Text] [Related]
14. Myeloma bone disease.
Berenson JR
Best Pract Res Clin Haematol; 2005; 18(4):653-72. PubMed ID: 16026743
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma/hypercalcemia.
Oyajobi BO
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
[TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding of myeloma bone disease and tumour growth.
Yaccoby S
Br J Haematol; 2010 May; 149(3):311-21. PubMed ID: 20230410
[TBL] [Abstract][Full Text] [Related]
17. Role of the microenvironment in multiple myeloma bone disease.
Huston A; Roodman GD
Future Oncol; 2006 Jun; 2(3):371-8. PubMed ID: 16787117
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of myeloma bone disease.
Roodman GD
Blood Cells Mol Dis; 2004; 32(2):290-2. PubMed ID: 15003820
[TBL] [Abstract][Full Text] [Related]
19. Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease.
Ji B; Genever PG; Patton RJ; Fagan MJ
Int J Numer Method Biomed Eng; 2014 Nov; 30(11):1085-102. PubMed ID: 24817420
[TBL] [Abstract][Full Text] [Related]
20. [Bone disease in multiple myeloma].
Irisawa H
Nihon Rinsho; 2015 Jan; 73(1):42-6. PubMed ID: 25626302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
